Cell-free DNA Study for Lymphoma Patients
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 517 (estimated)
- Sponsor
- M.D. Anderson Cancer Center · Other
This trial is looking for patients with diffuse large B-cell lymphoma who need treatment. Participants will provide blood samples before and after their treatment to help researchers understand the DNA found in the blood.
You may be able to join if
- I am at least 18 years old
- I have been diagnosed with diffuse large B-cell lymphoma
- I can provide written consent to participate
You may not be able to join if
- I am pregnant
- I have cognitive impairments
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityTo test the feasibility of collecting cell-free DNA (cfDNA) samples from DLBCL patients before and after treatment. cfDNA is DNA traveling in your blood outside of a cell and is easily collected from blood samples drawn using the vein puncture method.
Loading trial locations…